DOI: 10.1176/appi.ajp.158.7.1067. A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder

A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder
10.1176/appi.ajp.158.7.1067
Crossref journal-article
American Psychiatric Association Publishing
American Journal of Psychiatry (230)
Bibliography
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001). A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 158(7), 1067â1074.
Authors 9
Larry Scahill (first)
Phillip B. Chappell (additional)
Young S. Kim (additional)
Robert T. Schultz (additional)
Lily Katsovich (additional)
Elizabeth Shepherd (additional)
Amy F.T. Arnsten (additional)
Donald J. Cohen (additional)
James F. Leckman (additional)
References 53 Referenced 468
Dates
Type	When
Created	22 years, 10 months ago (Oct. 11, 2002, 2:10 p.m.)
Deposited	1 year, 1 month ago (July 24, 2024, 8:49 p.m.)
Indexed	1 week, 6 days ago (Aug. 23, 2025, 12:59 a.m.)
Issued	24 years, 2 months ago (July 1, 2001)
Published	24 years, 2 months ago (July 1, 2001)
Published Print	24 years, 2 months ago (July 1, 2001)
Funders 0
None
BibTeX
@article{Scahill_2001, title={A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder}, volume={158}, ISSN={1535-7228}, url={http://dx.doi.org/10.1176/appi.ajp.158.7.1067}, DOI={10.1176/appi.ajp.158.7.1067}, number={7}, journal={American Journal of Psychiatry}, publisher={American Psychiatric Association Publishing}, author={Scahill, Larry and Chappell, Phillip B. and Kim, Young S. and Schultz, Robert T. and Katsovich, Lily and Shepherd, Elizabeth and Arnsten, Amy F.T. and Cohen, Donald J. and Leckman, James F.}, year={2001}, month=jul, pages={1067–1074} }
JSON
{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        23
      ]
    ],
    "date-time": "2025-08-23T04:59:14Z",
    "timestamp": 1755925154811
  },
  "reference-count": 53,
  "publisher": "American Psychiatric Association Publishing",
  "issue": "7",
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2001,
        7,
        1
      ]
    ]
  },
  "DOI": "10.1176/appi.ajp.158.7.1067",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        10,
        11
      ]
    ],
    "date-time": "2002-10-11T18:10:43Z",
    "timestamp": 1034359843000
  },
  "page": "1067-1074",
  "source": "Crossref",
  "is-referenced-by-count": 468,
  "title": "A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder",
  "prefix": "10.1176",
  "volume": "158",
  "author": [
    {
      "given": "Larry",
      "family": "Scahill",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Phillip B.",
      "family": "Chappell",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Young S.",
      "family": "Kim",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Robert T.",
      "family": "Schultz",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Lily",
      "family": "Katsovich",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Elizabeth",
      "family": "Shepherd",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Amy F.T.",
      "family": "Arnsten",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Donald J.",
      "family": "Cohen",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "James F.",
      "family": "Leckman",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "230",
  "reference": [
    {
      "key": "R1587BABJDEGC",
      "doi-asserted-by": "crossref",
      "unstructured": "Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn J, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells K: Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996; 35:1304-1313",
      "DOI": "10.1097/00004583-199610000-00017"
    },
    {
      "key": "R1587BABDACAE",
      "doi-asserted-by": "crossref",
      "unstructured": "Swanson JM, Wigal S, Greenhill LL, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Baren M, Cantwell DP: Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry 1998; 37:519-526",
      "DOI": "10.1097/00004583-199805000-00014"
    },
    {
      "key": "R1587BABFHDIA",
      "doi-asserted-by": "crossref",
      "unstructured": "Erenberg G, Cruse RP, Rothner AD: Gilles de la Tourette\u2019s syndrome: effects of stimulant drugs. Neurology 1985; 35:1346-1348",
      "DOI": "10.1212/WNL.35.9.1346"
    },
    {
      "key": "atypb1",
      "doi-asserted-by": "crossref",
      "unstructured": "Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA: Stimulant medications precipitate Tourette\u2019s syndrome. JAMA 1982; 26:1729-1731",
      "DOI": "10.1001/jama.247.12.1729"
    },
    {
      "key": "R1587BABBJCFG",
      "doi-asserted-by": "crossref",
      "unstructured": "Lipkin PH, Goldstein IJ, Adesman AR: Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 1994; 148:859-861",
      "DOI": "10.1001/archpedi.1994.02170080089017"
    },
    {
      "key": "R1587BABDAHGD",
      "doi-asserted-by": "crossref",
      "unstructured": "Barkley RA, McMurray MB, Edelbrock CS, Robbins K: Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 1992; 86:184-192",
      "DOI": "10.1542/peds.86.2.184"
    },
    {
      "key": "R1587BABBAHGD",
      "doi-asserted-by": "crossref",
      "unstructured": "Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J: Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Res 1990; 33:83-94",
      "DOI": "10.1016/0165-1781(90)90151-T"
    },
    {
      "key": "R1587BABBIHHD",
      "doi-asserted-by": "crossref",
      "unstructured": "Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN: Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 1995; 52:444-455",
      "DOI": "10.1001/archpsyc.1995.03950180030005"
    },
    {
      "key": "R1587BABHCBDG",
      "doi-asserted-by": "crossref",
      "unstructured": "Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD, Rapoport JL: Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: effects of stimulants and dose. J Am Acad Child Adolesc Psychiatry 1997; 36:589-596",
      "DOI": "10.1097/00004583-199705000-00008"
    },
    {
      "key": "R1587BABEDABB",
      "doi-asserted-by": "crossref",
      "unstructured": "Riddle MA, Lynch KA, Scahill L, deVries A, Cohen DJ, Leckman JF: Effects of methylphenidate discontinuation and re-initiation in children with Tourette\u2019s syndrome and ADHD. J Child Adolesc Psychopharmacol 1995; 5:205-214",
      "DOI": "10.1089/cap.1995.5.205"
    },
    {
      "key": "R1587BABFDDJC",
      "doi-asserted-by": "crossref",
      "unstructured": "Law SF, Schachar RJ: Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 1999; 38:944-951",
      "DOI": "10.1097/00004583-199908000-00009"
    },
    {
      "key": "R1587BABCDJIH",
      "doi-asserted-by": "crossref",
      "unstructured": "Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S: Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 1999; 56:330-336",
      "DOI": "10.1001/archpsyc.56.4.330"
    },
    {
      "key": "R1587BABHEBJG",
      "doi-asserted-by": "crossref",
      "unstructured": "Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS: A double-blind placebo controlled study of desipramine in the treatment of ADD, I: efficacy. J Am Acad Child Adolesc Psychiatry 1989; 28:777-784",
      "DOI": "10.1097/00004583-198909000-00022"
    },
    {
      "key": "R1587BABDIJBB",
      "doi-asserted-by": "crossref",
      "unstructured": "Singer H, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB: The treatment of attention-deficit hyperactivity disorder in Tourette\u2019s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995; 95:74-81",
      "DOI": "10.1542/peds.95.1.74"
    },
    {
      "key": "R1587BABJHHBE",
      "doi-asserted-by": "crossref",
      "unstructured": "Riddle MA, Geller B, Ryan N: Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32:792-797",
      "DOI": "10.1097/00004583-199307000-00013"
    },
    {
      "key": "R1587BABJCJAC",
      "doi-asserted-by": "crossref",
      "unstructured": "Barrickman L, Perry P, Allen A, Kuperman S, Arndt S, Herrmann K, Schumacher E: Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:649-657",
      "DOI": "10.1097/00004583-199505000-00017"
    },
    {
      "key": "R1587BABCHBHE",
      "doi-asserted-by": "crossref",
      "unstructured": "Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J: Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1996; 34:1314-1321",
      "DOI": "10.1097/00004583-199610000-00018"
    },
    {
      "key": "R1587BABIFEJJ",
      "doi-asserted-by": "crossref",
      "unstructured": "Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M: Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder: clinical efficacy and side-effects. J Child Psychol Psychiatry 1996; 37:587-595",
      "DOI": "10.1111/j.1469-7610.1996.tb01445.x"
    },
    {
      "key": "R1587BABDFDCB",
      "doi-asserted-by": "crossref",
      "unstructured": "Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, Chapieski L, Trinidad K, Como P, Jankovic J: A controlled trial of deprenyl in children with Tourette\u2019s syndrome and attention deficit hyperactivity disorder. Neurology 1996; 46:965-968",
      "DOI": "10.1212/WNL.46.4.965"
    },
    {
      "key": "R1587BABHAEEC",
      "doi-asserted-by": "crossref",
      "unstructured": "Cohen DJ, Young JG, Nathanson JA, Shaywitz BA: Clonidine in Tourette\u2019s syndrome. Lancet 1979; 2:551-553",
      "DOI": "10.1016/S0140-6736(79)91614-3"
    },
    {
      "key": "R1587BABDDFHH",
      "doi-asserted-by": "crossref",
      "unstructured": "Connor DF, Barkley RA, Davis HT: A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr 2000; 39:15-25",
      "DOI": "10.1177/000992280003900102"
    },
    {
      "key": "atypb2",
      "doi-asserted-by": "crossref",
      "unstructured": "Hunt RD, Minderaa RB, Cohen DJ: Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Adolesc Psychiatry 1985; 24:617-629",
      "DOI": "10.1016/S0002-7138(09)60065-0"
    },
    {
      "key": "R1587BABFHHAC",
      "doi-asserted-by": "crossref",
      "unstructured": "Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ: Clonidine treatment of Gilles de la Tourette\u2019s syndrome. Arch Gen Psychiatry 1991; 48:324-328",
      "DOI": "10.1001/archpsyc.1991.01810280040006"
    },
    {
      "key": "R1587BABEJCGD",
      "doi-asserted-by": "crossref",
      "unstructured": "Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM: Clonidine and Gilles de la Tourette syndrome: double-blind study using objective rating methods. Ann Neurol 1987; 21:307-310",
      "DOI": "10.1002/ana.410210313"
    },
    {
      "key": "R1587BABDAGAJ",
      "doi-asserted-by": "crossref",
      "unstructured": "Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283:1025-1030",
      "DOI": "10.1001/jama.283.8.1025"
    },
    {
      "key": "R1587BABECHFB",
      "doi-asserted-by": "crossref",
      "unstructured": "Sorkin EM, Heel RC: Guanfacine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of hypertension. Drugs 1986; 31:301-336",
      "DOI": "10.2165/00003495-198631040-00003"
    },
    {
      "key": "R1587BABFEFBC",
      "doi-asserted-by": "crossref",
      "unstructured": "Avery R, Franowicz JCS, Studholme C, van Dyck CH, Arnsten AFT: The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex and improves accuracy in monkeys performing a spatial working memory task. Neuropsychopharmacology 2000; 23:240-249",
      "DOI": "10.1016/S0893-133X(00)00111-1"
    },
    {
      "key": "R1587BABBHIHB",
      "doi-asserted-by": "crossref",
      "unstructured": "Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Schubert AB, Vauss YC, Vaituzis AC, Dickstein DP, Sarfatti SE, Rapoport JL: Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolescent Psychiatry 1997; 36:374-383",
      "DOI": "10.1097/00004583-199703000-00016"
    },
    {
      "key": "R1587BABGFJEC",
      "doi-asserted-by": "crossref",
      "unstructured": "Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz RT, Arnsten AFT, Leckman JF, Cohen DJ: Guanfacine treatment of comorbid attention-deficit hyperactivity disorder in Tourette\u2019s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995; 34:1140-1146",
      "DOI": "10.1097/00004583-199509000-00010"
    },
    {
      "key": "atypb3",
      "doi-asserted-by": "crossref",
      "unstructured": "Horrigan JP, Barnhill LJ: Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 1995; 5:215-223",
      "DOI": "10.1089/cap.1995.5.215"
    },
    {
      "key": "R1587BABCHDIH",
      "doi-asserted-by": "crossref",
      "unstructured": "Hunt RD, Arnsten AFT, Asbell MD: An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:50-54",
      "DOI": "10.1097/00004583-199501000-00013"
    },
    {
      "key": "R1587BABCBJEA",
      "doi-asserted-by": "crossref",
      "unstructured": "Goyette CH, Conners CK, Ulrich RF: Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 1978; 6:221-236",
      "DOI": "10.1007/BF00919127"
    },
    {
      "key": "R1587BABBJEBE",
      "doi-asserted-by": "crossref",
      "unstructured": "Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ: The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28:566-573",
      "DOI": "10.1097/00004583-198907000-00015"
    },
    {
      "key": "R1587BABGGGDB",
      "doi-asserted-by": "crossref",
      "unstructured": "Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF: Children\u2019s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36:844-852",
      "DOI": "10.1097/00004583-199706000-00023"
    },
    {
      "key": "R1587BABDDBII",
      "unstructured": "DuPaul GJ, Anastopoulos AD, Power TJ, Reid R, Ikeda MJ, MacGoey KE: Parent ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. J Psychopathology and Behavioral Assessment 1998; 20:57-81"
    },
    {
      "key": "R1587BABJAEAE",
      "doi-asserted-by": "crossref",
      "unstructured": "DuPaul GJ, Anastopoulos AD, MacGoey KE, Power TJ, Reid R, Ikeda MJ: Teacher ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. Psychol Assess 1998; 9:436-444",
      "DOI": "10.1037//1040-3590.9.4.436"
    },
    {
      "key": "R1587BABCDEFI",
      "doi-asserted-by": "crossref",
      "unstructured": "Rosvold HE, Mirsky AF, Sarason I, Bransome ED, Beck LH: A continuous performance test of brain damage. J Consult Psychol 1956; 20:343-350",
      "DOI": "10.1037/h0043220"
    },
    {
      "key": "R1587BABEJIAD",
      "unstructured": "Conners CK, Barkley RA: Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 1985; 21:809-843"
    },
    {
      "key": "R1587BABEGAID",
      "unstructured": "Levine J, Schooler N: SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986; 22:343-381"
    },
    {
      "key": "R1587BABCBAFG",
      "doi-asserted-by": "crossref",
      "unstructured": "National Heart, Lung and Blood Institute: Report of the Second Task Force on Blood Pressure Control in Children\u20141987. Pediatrics 1987; 79:1-25",
      "DOI": "10.1542/peds.79.1.1"
    },
    {
      "key": "R1587BABBFBGJ",
      "doi-asserted-by": "crossref",
      "unstructured": "Rapport MD, Denney C, DuPaul GJ, Gardner MJ: Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 1994; 33:882-893",
      "DOI": "10.1097/00004583-199407000-00015"
    },
    {
      "key": "R1587BABDGECD",
      "doi-asserted-by": "crossref",
      "unstructured": "Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandell J, Nordlie J, Phillips RA: Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette\u2019s syndrome. Arch Gen Psychiatry 1989; 46:722-730",
      "DOI": "10.1001/archpsyc.1989.01810080052006"
    },
    {
      "key": "R1587BABCEEHG",
      "doi-asserted-by": "crossref",
      "unstructured": "Eggers CH, Rothenberger A, Berghaus U: Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988; 237:223-229",
      "DOI": "10.1007/BF00449911"
    },
    {
      "key": "R1587BABGBDIH",
      "doi-asserted-by": "crossref",
      "unstructured": "Sallee FR, Kurlan R, Goetz C, Singer H, Scahill L, Law G, Dittman VM, Chappell PB: Ziprasidone treatment of children and adolescents with Tourette\u2019s syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000; 39:292-299",
      "DOI": "10.1097/00004583-200003000-00010"
    },
    {
      "key": "R1587BABJEBEI",
      "doi-asserted-by": "crossref",
      "unstructured": "Li BM, Mao ZM, Wang M, Mei ZT: Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology 1999; 21:601-610",
      "DOI": "10.1016/S0893-133X(99)00070-6"
    },
    {
      "key": "R1587BABGBDDF",
      "doi-asserted-by": "crossref",
      "unstructured": "Mao ZM, Arnsten AFT, Li BM: Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol Psychiatry 1999; 46:1259-1265",
      "DOI": "10.1016/S0006-3223(99)00139-0"
    },
    {
      "key": "R1587BABHCBFH",
      "unstructured": "Ernsberger P, Giuliano R, Willette RN, Reis DJ: Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 1990; 253:408-418"
    },
    {
      "key": "R1587BABJCEEH",
      "doi-asserted-by": "crossref",
      "unstructured": "Berridge CW, Foote SL: Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 1991; 11:3135-3145",
      "DOI": "10.1523/JNEUROSCI.11-10-03135.1991"
    },
    {
      "key": "R1587BABJAADF",
      "doi-asserted-by": "crossref",
      "unstructured": "Buzsaki G, Kennedy B, Solt VB, Ziegler M: Noradrenergic control of thalamic oscillation: the role of a-2 receptors. Eur J Neurol 1991; 3:222-229",
      "DOI": "10.1111/j.1460-9568.1991.tb00083.x"
    },
    {
      "key": "R1587BABEDFCH",
      "doi-asserted-by": "crossref",
      "unstructured": "Engberg G, Eriksson E: Effects of a-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats. Naunyn Schmiedebergs Arch Pharmacol 1991; 343:472-477",
      "DOI": "10.1007/BF00169548"
    },
    {
      "key": "R1587BABDIAEB",
      "doi-asserted-by": "crossref",
      "unstructured": "Horrigan JP, Barnhill J: Does guanfacine trigger mania in children? J Child Adolesc Psychopharmacol 1998; 8:149-150",
      "DOI": "10.1089/cap.1998.8.149"
    },
    {
      "key": "R1587BABHEAEI",
      "doi-asserted-by": "crossref",
      "unstructured": "Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R, Ringel R, Shaddy R, Taubert K: Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation 1999; 99:979-982",
      "DOI": "10.1161/01.CIR.99.7.979"
    },
    {
      "key": "R1587BABEHHFD",
      "doi-asserted-by": "crossref",
      "unstructured": "Leckman JF, Ort S, Caruso KA, Anderson GM, Riddle MA, Cohen DJ: Rebound phenomena in Tourette\u2019s syndrome after abrupt withdrawal of clonidine. Arch Gen Psychiatry 1986; 43:1168-1176",
      "DOI": "10.1001/archpsyc.1986.01800120054011"
    }
  ],
  "container-title": "American Journal of Psychiatry",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://psychiatryonline.org/doi/10.1176/appi.ajp.158.7.1067",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2024,
        7,
        25
      ]
    ],
    "date-time": "2024-07-25T00:49:52Z",
    "timestamp": 1721868592000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://psychiatryonline.org/doi/10.1176/appi.ajp.158.7.1067"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2001,
        7,
        1
      ]
    ]
  },
  "references-count": 53,
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2001,
          7,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "10.1176/appi.ajp.158.7.1067"
  ],
  "URL": "http://dx.doi.org/10.1176/appi.ajp.158.7.1067",
  "relation": {},
  "ISSN": [
    "0002-953X",
    "1535-7228"
  ],
  "subject": [],
  "container-title-short": "AJP",
  "published": {
    "date-parts": [
      [
        2001,
        7,
        1
      ]
    ]
  }
}